Necrosis of the Donor Site After Hair Restoration With Follicular Unit Extraction: A Case Report

    July 2011 in “ Journal of Plastic Reconstructive and Aesthetic Surgery ”
    Naci Karaçal, Muhammet Uraloğlu, Taner Dindar, Murat Livaoğlu
    Image of study
    TLDR A patient had skin tissue death at the hair removal site after a hair transplant, which was treated with surgery.
    In the 2012 case report, a 22-year-old male patient experienced necrosis of the donor site following a follicular unit extraction (FUE) hair restoration procedure, which led to cicatricial alopecia in the left occipital region. The patient had a family history of early hair loss and was diagnosed with Norwood class III androgenic alopecia. During the procedure, 950 follicles were removed using 0.8-mm punches, and postoperatively, an area of 6 × 8 cm of necrotic tissue developed around the extraction sites. The necrosis was treated by debridement and secondary healing, followed by a two-stage surgical intervention with tissue expanders to address the resulting cicatricial alopecia. The patient recovered without further complications. The report suggests that while FUE has many advantages, such as less pain and scarring, the risk of donor site necrosis is a serious potential complication. The authors emphasize the importance of using suitable concentrations of vasoconstrictor agents and monitoring for ischemia in the donor area during and after the procedure.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 171 results

      community Verteporfin and Microneedling

      in Treatments 6 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

      community How is verteporfin doing in trials?

      in Chat  9 upvotes 1 year ago
      The conversation is about the progress of verteporfin in hair loss trials, with users expressing curiosity about its effectiveness and updates. Specific treatments mentioned include FUE (Follicular Unit Extraction) combined with verteporfin, with one reported case of donor area regrowth after a year, and three patients being monitored post-treatment by Dr. Bloxham with monthly updates on YouTube.

    Similar Research

    5 / 1000+ results
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.
      Medical Treatment of Alopecia

      research Medical Treatment of Alopecia

      October 2018 in “InTech eBooks”
      The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.